$TEVA Market Cap:
Research Board Inbox Deep Research Not Interested Shortlisted

$TEVA SEC Filings

Filing Filed On
TEVA AND PROCOGNIA (ISRAEL) LTD. SIGN AN EXCLUSIVE COLLABORATION AGREEMENT FOR T 25 Sep 2006
LAQUINIMOD PHASE IIB TRIAL CONFIRMS EFFICACY AND FAVORABLE SAFETY PROFILE AND SH 05 Sep 2006
TEVA ANNOUNCES HEALTH CANADA APPROVES AZILECT? (RASAGILINE) FOR PARKINSON???S D 29 Aug 2006
TEVA ANNOUNCES FURTHER STEPS IN GLOBAL RATIONALIZATION STRATEGY 24 Aug 2006
PROXY STATEMENT FOR THE SPECIAL MEETING OF SHAREHOLDERS 24 Aug 2006
TEVA ANNOUNCES HEALTH CANADA APPROVES AZILECT? (RASAGILINE) FOR PARKINSON???S D 21 Aug 2006
FORM 6-K 14 Aug 2006
TEVA ANNOUNCES LAUNCH OF GENERIC ZOLOFT? 14 Aug 2006
TEVA REPORTS SECOND QUARTER 2006 RESULTS 08 Aug 2006
TEVA ANNOUNCES FINAL APPROVAL OF VENLAFAXINE HCL TABLETS 07 Aug 2006
TEVA ANNOUNCES GLOBAL IN-MARKET SECOND QUARTER SALES OF COPAXONE? INCREASED 22% 02 Aug 2006
TEVA INITIATES PHASE III STUDY TO CONFIRM INCREASED EFFICACY OF HIGHER DOSE OF G 27 Jul 2006
TEVA TO REPORT SECOND QUARTER 2006 FINANCIAL RESULTS ON AUGUST 8, 2006 26 Jul 2006
TEVA ANNOUNCES FINAL APPROVAL OF MELOXICAM TABLETS 24 Jul 2006
TEVA ANNOUNCES FINAL APPROVAL OF MELOXICAM TABLETS 24 Jul 2006
TEVA WILL BE SOLE PROMOTER OF AZILECT? FOR PARKINSON'S DISEASE IN THE UNITED STA 12 Jul 2006
TEVA RECEIVES FDA APPROVAL FOR GENERIC ZOLOFT? TABLETS 05 Jul 2006
TEVA PROVIDES GENERIC BIAXIN? XL UPDATE 28 Jun 2006
TEVA ANNOUNCES NOVARTIS' SANDOZ UNIT SEEKS TO DELAY FIRST FDA APPROVAL OF GENERI 26 Jun 2006
TEVA RECEIVES FIRST U.S. APPROVAL OF GENERIC ZOCOR? TABLETS; PRODUCT TO BE SHIPP 26 Jun 2006